ASCO 2025: Phase III ARANOTE Post-hoc Analyses Presented on Health-Related Quality of Life and Pain Outcomes in Patients with Metastatic Castration-Sensitive Prostate Cancer Receiving NUBEQA® (darolutamide) plus ADT
WHIPPANY, N.J.--(BUSINESS WIRE)--New post-hoc analyses from the investigational Phase III ARANOTE trial showed a clinically meaningful improvement in health-related quality of life (HRQoL) and delayed pain progression for metastatic castration-sensitive prostate cancer (mCSPC) patients treated with NUBEQA® (darolutamide) plus androgen deprivation therapy (ADT) versus patients treated with placebo plus ADT.1 The results will be presented at the 2025 American Society of Clinical Oncology (ASCO) A.
4 Sizzling Buy-Rated Stocks Trading Under $10 With Massive Upside Potential
While most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
Adriatic Metals reports quarter of growth as Vares ramp up continues
Adriatic Metals PLC (LSE:ADT1, ASX:ADT, OTCQX:ADMLF) highlighted ‘a period of progress' at the Vares Silver, as it reported on its first quarter. The junior miner reported a 46% increase in silver equivalent production to 1.4 million ounces in the quarter.
ADT: Solid Quarter Adds Confidence To Potential Growth Acceleration
I maintain a buy rating for ADT, driven by solid 1Q25 results, improved fundamentals, and promising growth prospects with the ADT+ platform. ADT's 1Q25 earnings showed 7% y/y revenue growth, margin expansion, and a record-low customer churn rate, highlighting the essential nature of its services. The ADT+ Translator and Trusted Neighbor features are strategic upgrades, enhancing customer retention and monetization, thus expanding ADT's addressable revenue base.
Are Investors Undervaluing ADT (ADT) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
ADT Inc. (ADT) Q1 2025 Earnings Call Transcript
ADT Inc. (NYSE:ADT ) Q1 2025 Earnings Conference Call April 24, 2025 10:00 AM ET Company Participants Elizabeth Landers - Investor Relations Jim DeVries - Chairman, President & Chief Executive Officer Jeff Likosar - Chief Financial Officer Conference Call Participants Ronan Kennedy - Barclays George Tong - Goldman Sachs David Paige - RBC Capital Markets Peter Christiansen - Citigroup Yehuda Silverman - Morgan Stanley Operator Hello, and welcome to the ADT First Quarter 2025 Earnings Conference Call. All lines have been placed on mute to prevent any background noise.
ADT (ADT) Surpasses Q1 Earnings and Revenue Estimates
ADT (ADT) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.16 per share a year ago.
ADT Reports First Quarter 2025 Results
Continued strong financial results with record recurring monthly revenue and customer retention GAAP operating cash flows up 28%, Adjusted Free Cash Flow including interest rate swaps up 105% Returned $445 million to shareholders through share repurchases and dividends On track to achieve full year 2025 guidance metrics BOCA RATON, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) today reported results for the first quarter of 2025.
ADT To Release First Quarter 2025 Results On Thursday, April 24, 2025
BOCA RATON, Fla., April 10, 2025 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) will release its first quarter 2025 financial results before the market opens on Thursday, April 24, 2025.
Is ADT (ADT) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Beyrich's Picks: ADT, DOW, PFE, AMCR, BERY
Eric Beyrich says, “this is the time of year we actually thrive” as he looks at a low-bid, high-yield strategy. He compares the ratio of value to growth in the market and says there's a “long way to go” to get back to equilibrium after tech's massive run.
Pick These 5 Bargain Stocks With Impressive EV-to-EBITDA Ratios
We have screened bargain stocks HPK, BJRI, PRAA, AZZ and ADT based on the EV-to-EBITDA ratio, which gives the true picture of valuation and earnings potential.
